Barrington Research Analysts Lift Earnings Estimates for Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Equities researchers at Barrington Research boosted their FY2024 EPS estimates for shares of Option Care Health in a research report issued to clients and investors on Wednesday, April 24th. Barrington Research analyst M. Petusky now anticipates that the company will earn $1.15 per share for the year, up from their prior estimate of $1.10. Barrington Research has a “Outperform” rating and a $38.00 price objective on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.17 per share. Barrington Research also issued estimates for Option Care Health’s FY2025 earnings at $1.35 EPS.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the prior year, the firm earned $0.21 earnings per share. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year.

Separately, Jefferies Financial Group boosted their price target on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $29.29 on Friday. Option Care Health has a fifty-two week low of $24.23 and a fifty-two week high of $35.74. The firm’s 50 day moving average is $32.04 and its two-hundred day moving average is $31.50. The company has a market cap of $5.09 billion, a P/E ratio of 19.27, a P/E/G ratio of 1.65 and a beta of 1.22. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Institutional Trading of Option Care Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Mutual of America Capital Management LLC lifted its stake in Option Care Health by 63.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 190,684 shares of the company’s stock valued at $6,424,000 after buying an additional 73,938 shares during the last quarter. Wellington Management Group LLP lifted its position in Option Care Health by 15.9% in the 3rd quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company’s stock valued at $93,698,000 after purchasing an additional 397,627 shares during the last quarter. HealthInvest Partners AB acquired a new position in Option Care Health during the 4th quarter valued at about $1,254,000. Ontario Teachers Pension Plan Board bought a new position in Option Care Health in the 3rd quarter worth about $546,000. Finally, Van ECK Associates Corp increased its stake in shares of Option Care Health by 244.2% in the third quarter. Van ECK Associates Corp now owns 34,291 shares of the company’s stock valued at $1,109,000 after purchasing an additional 24,328 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of Option Care Health stock in a transaction on Monday, February 26th. The shares were bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the purchase, the director now directly owns 269,528 shares in the company, valued at approximately $8,503,608.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.